会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PHARMACEUTICAL COMPOSITION CONTAINING PUERARIAE FLOS EXTRACTS AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING ENDOMETRIOSIS
    • 含有普鲁兰酶提取物作为活性成分的药物组合物作为预防和治疗子宫内膜异位症的活性成分
    • WO2013043011A3
    • 2013-05-23
    • PCT/KR2012007653
    • 2012-09-24
    • UNIV KYUNG HEE UNIV IND COOP GROUP
    • CHOI JUNG-HYEKIM JI-HYYUN
    • A61K36/488A61P15/00
    • A61K36/488A23L33/105
    • The present invention relates to a pharmaceutical composition containing Puerariae flos extracts as active ingredients for preventing or treating endometriosis and the complications thereof. More particularly, Puerariae flos extracts exhibit the activity of inhibiting the migration and adhesion of endometrial cells, inhibiting the expression of MMP-2 and MMP-9, which are factors associated with migration and adhesion, inhibiting the expression of COX-2, which is a factor associated with pain, and inhibiting the expression of MCP-1, which is a cytokine associated with inflammation and RANTES. Therefore, the Puerariae flos extracts of the present invention can be effectively used as active ingredients for a pharmaceutical composition for preventing and treating endometriosis and the complications thereof, and for a health food.
    • 本发明涉及含有葛根提取物作为活性成分的药物组合物,用于预防或治疗子宫内膜异位症及其并发症。 更具体地说,葛根提取物具有抑制子宫内膜细胞迁移和粘附的活性,抑制作为迁移和粘附相关因子的MMP-2和MMP-9的表达,抑制COX-2的表达,其是 与疼痛相关的因素,并抑制与炎症和RANTES相关的细胞因子MCP-1的表达。 因此,本发明的葛根提取物可以有效地用作预防和治疗子宫内膜异位症及其并发症和保健食品的药物组合物的活性成分。